title: [Role of radiotherapy in the management of adenocarcinoma of the breast accessible to conservative surgery].
abstract: Standard treatment for limited stage adenocarcinoma of the breast includes lumpectomy (or a quadrantectomy), axillary node dissection, regional radiation therapy and, if the prognostic factors are unfavourable, chemotherapy and/or hormone therapy. This is supported by the results of American and European randomised trials. There have been many attempts at improving the modalities of conservative surgery and postoperative radiation therapy in order to maximize local control and minimize late sequellae. It is also likely that induction chemotherapy and external beam radiotherapy applied in selected cases increase the proportion of patients who can be offered conservative surgery.
authors.affiliation: Service de radiothérapie-oncologie, centre hospitalier Lyon-Sud, Pierre, France.
authors.forename: P
authors.initials: P
authors.lastname: Romestaing
authors.forename: J J
authors.initials: JJ
authors.lastname: Mazeron
authors.forename: R
authors.initials: R
authors.lastname: Coquard
authors.forename: J M
authors.initials: JM
authors.lastname: Ardiet
authors.forename: F
authors.initials: F
authors.lastname: Mornex
authors.forename: J P
authors.initials: JP
authors.lastname: Gérard
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects*; D016019:Survival Analysis; D016896:Treatment Outcome